Michael P. Samar - Jul 25, 2022 Form 4 Insider Report for ASSEMBLY BIOSCIENCES, INC. (ASMB)

Role
Chief Financial Officer
Signature
/s/ John O. Gunderson, as Attorney-in-Fact
Stock symbol
ASMB
Transactions as of
Jul 25, 2022
Transactions value $
-$4,479
Form type
4
Date filed
7/26/2022, 05:00 PM
Previous filing
Jun 27, 2022
Next filing
Jun 26, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASMB Common Stock Sale -$4.48K -2.02K -2.55% $2.22 77.2K Jul 25, 2022 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and represents shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.14 to $2.25, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.
F3 Includes 2,500 shares acquired under the Assembly Biosciences, Inc. Amended and Restated 2018 Employee Stock Purchase Plan on May 13, 2022.